Thomas W. Arnst - Mar 1, 2024 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)

Signature
Chad J. Wiener, as Attorney-in-Fact for Thomas W. Arnst
Stock symbol
THC
Transactions as of
Mar 1, 2024
Transactions value $
-$1,819,955
Form type
4
Date filed
3/5/2024, 08:00 PM
Previous filing
Mar 1, 2024
Next filing
May 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THC Common Stock Options Exercise +5.6K +25.73% 27.4K Mar 1, 2024 Direct F2
transaction THC Common Stock Tax liability -$208K -2.2K -8.05% $94.29 25.1K Mar 1, 2024 Direct F3, F4
transaction THC Common Stock Sale -$374K -3.98K -15.81% $94.03 21.2K Mar 1, 2024 Direct F5
transaction THC Common Stock Sale -$942K -9.93K -46.88% $94.96 11.2K Mar 1, 2024 Direct F6
transaction THC Common Stock Sale -$296K -3.1K -27.55% $95.48 8.15K Mar 1, 2024 Direct F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THC 2023 March Restricted Stock Units Options Exercise $0 +5.6K +99.96% $0.00 11.2K Mar 1, 2024 Common Stock 5.6K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on March 1, 2024.
F2 Restricted stock units convert into common stock on a one-for-one basis.
F3 Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
F4 Represents the closing price of the common stock of the Issuer on March 1, 2024.
F5 The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $93.395 to $94.39. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F6 The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $94.395 to $95.37. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F7 The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $95.40 to $95.62. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.